TAE Life Sciences
  • ABOUT US
    • WE ARE TAE LIFE SCIENCES
    • BOARD OF DIRECTORS
    • MANAGEMENT TEAM
  • ABOUT BNCT
  • OUR NEUTRON SOURCE
  • PARTNERS
  • NEWS
  • CAREERS
  • CONTACT
  • ABOUT US
    • WE ARE TAE LIFE SCIENCES
    • BOARD OF DIRECTORS
    • MANAGEMENT TEAM
  • ABOUT BNCT
  • OUR NEUTRON SOURCE
  • PARTNERS
  • NEWS
  • CAREERS
  • CONTACT

$40 Million for Boron Neutron Capture Therapy

Home > News > $40 Million for Boron Neutron Capture Therapy
March 13, 2018
Chemical & Engineering News
Chemical & Engineering News

2018 | Chemical & Engineering News | Read Now

TAE Life Sciences aims to commercialize a cancer radiation treatment called Boron Neutron Capture Therapy. In BNCT, boron-10 is administered to tumors, irradiated with a beam of neutrons, and broken down into charged particles that kill cancer cells.

Previous StoryA Surprise Application To Cancer
Next StoryTAE Raises $40M To Develop New Targeted Radiotherapy

Related Articles

  • robert-hill-color
    TAE Life Sciences Adds Seasoned Chief Operating Officer to Scale New Radiation Treatment Platform
  • BioWorld MedTech
    New TAE Unit Launched To Treat Cancers Gains $40M In Financing And Closes Partnership Deal

Archive

  • January 2019 (1)
  • November 2018 (1)
  • March 2018 (9)

Archive As Dropdown

Calendar

February 2019
M T W T F S S
« Jan    
 123
45678910
11121314151617
18192021222324
25262728  

Categories Dropdown

Categories

  • Careers (1)
  • News (10)

Recent Comments

    Tag Cloud

    Careers News

    Text

    Vivamus ante dolor, lobortis sit amet magna tempus, congue dapibus mauris. Sed tempor, sapien convallis bibendum scelerisque, libero eros imperdiet quam, quis molestie augue nisi in turpis!

    Flickr-Tf

    TAE Life Sciences
    • ABOUT US
    • ABOUT BNCT
    • OUR NEUTRON SOURCE
    • PARTNERS
    • CONTACT

    Copyright ©2019 TAE Life Sciences. All Rights Reserved.

    * The device being developed by TAE Life Sciences is for investigational use only and has not been approved for sale or commercial use.